Robert N Fried insider trades

Open-market stock purchases and sales by Robert N Fried, Chief Executive Officer at Niagen Bioscience, Inc, from SEC Form 4 filings since Jan 11, 2010.

Recent trades

DateStockTradeValue
Jun 30, 2026NAGE Niagen Bioscience, IncBought (not open market)$3K
Apr 24, 2026NAGE Niagen Bioscience, IncBought (not open market)—
Feb 19, 2026NAGE Niagen Bioscience, IncBought (not open market)—

Companies traded

  • NAGE Niagen Bioscience, Inc: other filings, last Jun 30, 2026
  • CDXC ChromaDex Corp: 12 buys, last Feb 25, 2025
  • COGT Cogint, Inc: 1 buy, last Apr 13, 2017
  • IDI IDI, Inc: other filings, last Jun 1, 2016
  • CDXC.OB ChromaDex Corp: 1 sale, last Jan 29, 2016

Get free alerts when Robert N Fried files a new trade →